サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1123915

世界の帯状疱疹ワクチン市場：考察と予測 (2028年まで)

Global Shingles Vaccine Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 109 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の帯状疱疹ワクチン市場：考察と予測 (2028年まで)
出版日: 2022年09月09日
発行: QYResearch
ページ情報: 英文 109 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、帯状疱疹ワクチン (Shingles Vaccine) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 帯状疱疹ワクチンの製品概要
  • 市場：タイプ別
    • 世界の帯状疱疹ワクチン 市場規模：タイプ別, 2017 VS 2021 VS 2028
    • Zostavax
    • Shingrix
  • 市場：アプリケーション別
    • 世界の帯状疱疹ワクチン 市場規模：アプリケーション別, 2017 VS 2021 VS 2028
    • Under 50 Years Old
    • 50-60 Years Old
    • 60-70 Years Old
    • Above 70 Years Old
  • 調査目的
  • 対象期間

第2章 世界の帯状疱疹ワクチンの生産

  • 世界の帯状疱疹ワクチンの生産能力 (2017-2028)
  • 世界の帯状疱疹ワクチンの生産：地域別: 2017 VS 2021 VS 2028
  • 世界の帯状疱疹ワクチンの生産：地域別
    • 世界の帯状疱疹ワクチンの生産実績：地域別 (2017-2022)
    • 世界の帯状疱疹ワクチンの生産予測：地域別 (2023-2028)
  • 北米
  • 欧州
  • 中国
  • 日本

第3章 世界の帯状疱疹ワクチンの販売（数量・金額）推定および予測

  • 世界の帯状疱疹ワクチンの販売 推定および予測 2017-2028
  • 世界の帯状疱疹ワクチンの収益 推定および予測 2017-2028
  • 世界の帯状疱疹ワクチンの収益：地域別: 2017 VS 2021 VS 2028
  • 世界の帯状疱疹ワクチンの販売：地域別
    • 世界の帯状疱疹ワクチンの販売：地域別 (2017-2022)
    • 世界の販売 帯状疱疹ワクチン ：地域別 (2023-2028)
  • 世界の帯状疱疹ワクチンの収益：地域別
    • 世界の帯状疱疹ワクチンの収益：地域別 (2017-2022)
    • 世界の帯状疱疹ワクチンの収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第4章 競合：メーカー別

  • 世界の帯状疱疹ワクチンの生産能力：メーカー別
  • 世界の帯状疱疹ワクチンの販売：メーカー別
    • 世界の帯状疱疹ワクチンの販売：メーカー別 (2017-2022)
    • 世界の帯状疱疹ワクチンの販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： 帯状疱疹ワクチン2021
  • 世界の帯状疱疹ワクチンの収益：メーカー別
    • 世界の帯状疱疹ワクチンの収益：メーカー別 (2017-2022)
    • 世界の帯状疱疹ワクチンの収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： 帯状疱疹ワクチンの収益 2021
  • 世界の帯状疱疹ワクチンの販売価格：メーカー別
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界の帯状疱疹ワクチンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界の帯状疱疹ワクチンのメーカーの地理的分布
  • M&A, 拡張計画

第5章 市場規模：タイプ別

  • 世界の帯状疱疹ワクチンの販売：タイプ別
    • 世界の帯状疱疹ワクチンの販売実績：タイプ別 (2017-2022)
    • 世界の帯状疱疹ワクチンの販売予測：タイプ別 (2023-2028)
    • 世界の帯状疱疹ワクチンの販売市場シェア：タイプ別 (2017-2028)
  • 世界の帯状疱疹ワクチンの収益：タイプ別
    • 世界の帯状疱疹ワクチンの収益実績：タイプ別 (2017-2022)
    • 世界の帯状疱疹ワクチンの収益予測：タイプ別 (2023-2028)
    • 世界の帯状疱疹ワクチンの収益市場シェア：タイプ別 (2017-2028)
  • 世界の帯状疱疹ワクチンの価格：タイプ別
    • 世界の帯状疱疹ワクチンの価格：タイプ別 (2017-2022)
    • 世界の帯状疱疹ワクチンの価格予測：タイプ別 (2023-2028)

第6章 市場規模：アプリケーション別

  • 世界の帯状疱疹ワクチンの販売：アプリケーション別
    • 世界の帯状疱疹ワクチンの販売実績：アプリケーション別 (2017-2022)
    • 世界の帯状疱疹ワクチンの販売予測：アプリケーション別 (2023-2028)
    • 世界の帯状疱疹ワクチンの販売市場シェア：アプリケーション別 (2017-2028)
  • 世界の帯状疱疹ワクチンの収益：アプリケーション別
    • 世界の帯状疱疹ワクチンの収益実績：アプリケーション別 (2017-2022)
    • 世界の帯状疱疹ワクチンの収益予測：アプリケーション別 (2023-2028)
    • 世界の帯状疱疹ワクチンの収益市場シェア：アプリケーション別 (2017-2028)
  • 世界の帯状疱疹ワクチンの価格：アプリケーション別
    • 世界の帯状疱疹ワクチンの価格：アプリケーション別 (2017-2022)
    • 世界の帯状疱疹ワクチンの価格予測：アプリケーション別 (2023-2028)

第7章 北米

  • 北米の帯状疱疹ワクチン 市場規模：タイプ別
    • 北米の帯状疱疹ワクチンの販売：タイプ別 (2017-2028)
    • 北米の帯状疱疹ワクチンの収益：タイプ別 (2017-2028)
  • 北米の帯状疱疹ワクチン 市場規模：アプリケーション別
    • 北米の帯状疱疹ワクチンの販売：アプリケーション別 (2017-2028)
    • 北米の帯状疱疹ワクチンの収益：アプリケーション別 (2017-2028)
  • 北米の帯状疱疹ワクチンの販売：国別
    • 北米の帯状疱疹ワクチンの販売：国別 (2017-2028)
    • 北米の帯状疱疹ワクチンの収益：国別 (2017-2028)
    • 米国
    • カナダ

第8章 欧州

  • 欧州の帯状疱疹ワクチン 市場規模：タイプ別
    • 欧州の帯状疱疹ワクチンの販売：タイプ別 (2017-2028)
    • 欧州の帯状疱疹ワクチンの収益：タイプ別 (2017-2028)
  • 欧州の帯状疱疹ワクチン 市場規模：アプリケーション別
    • 欧州の帯状疱疹ワクチンの販売：アプリケーション別 (2017-2028)
    • 欧州の帯状疱疹ワクチンの収益：アプリケーション別 (2017-2028)
  • 欧州の帯状疱疹ワクチンの販売：国別
    • 欧州の帯状疱疹ワクチンの販売：国別 (2017-2028)
    • 欧州の帯状疱疹ワクチンの収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第9章 アジア太平洋

  • アジア太平洋の帯状疱疹ワクチン 市場規模：タイプ別
    • アジア太平洋の帯状疱疹ワクチンの販売：タイプ別 (2017-2028)
    • アジア太平洋の帯状疱疹ワクチンの収益：タイプ別 (2017-2028)
  • アジア太平洋の帯状疱疹ワクチン 市場規模：アプリケーション別
    • アジア太平洋の帯状疱疹ワクチンの販売：アプリケーション別 (2017-2028)
    • アジア太平洋の帯状疱疹ワクチンの収益：アプリケーション別 (2017-2028)
  • アジア太平洋の帯状疱疹ワクチンの販売：地域別
    • アジア太平洋の帯状疱疹ワクチンの販売：地域別 (2017-2028)
    • アジア太平洋の帯状疱疹ワクチンの収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第10章 ラテンアメリカ

  • ラテンアメリカの帯状疱疹ワクチン 市場規模：タイプ別
    • ラテンアメリカの帯状疱疹ワクチンの販売：タイプ別 (2017-2028)
    • ラテンアメリカの帯状疱疹ワクチンの収益：タイプ別 (2017-2028)
  • ラテンアメリカの帯状疱疹ワクチン 市場規模：アプリケーション別
    • ラテンアメリカの帯状疱疹ワクチンの販売：アプリケーション別 (2017-2028)
    • ラテンアメリカの帯状疱疹ワクチンの収益：アプリケーション別 (2017-2028)
  • ラテンアメリカの帯状疱疹ワクチンの販売：国別
    • ラテンアメリカの帯状疱疹ワクチンの販売：国別 (2017-2028)
    • ラテンアメリカの帯状疱疹ワクチンの収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第11章 中東・アフリカ

  • 中東・アフリカの帯状疱疹ワクチン 市場規模：タイプ別
    • 中東・アフリカの帯状疱疹ワクチンの販売：タイプ別 (2017-2028)
    • 中東・アフリカの帯状疱疹ワクチンの収益：タイプ別 (2017-2028)
  • 中東・アフリカの帯状疱疹ワクチン 市場規模：アプリケーション別
    • 中東・アフリカの帯状疱疹ワクチンの販売：アプリケーション別 (2017-2028)
    • 中東・アフリカの帯状疱疹ワクチンの収益：アプリケーション別 (2017-2028)
  • 中東・アフリカの帯状疱疹ワクチンの販売：国別
    • 中東・アフリカの帯状疱疹ワクチンの販売：国別 (2017-2028)
    • 中東・アフリカの帯状疱疹ワクチンの収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア
    • U.A.E

第12章 企業プロファイル

  • Merck
  • GlaxoSmithKline

第13章 業界チェーンと販売チャネルの分析

  • 帯状疱疹ワクチン 業界チェーン分析
  • 帯状疱疹ワクチン 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 帯状疱疹ワクチン 生産形態とプロセス
  • 帯状疱疹ワクチン 販売およびマーケティング
    • 帯状疱疹ワクチン 販売チャネル
    • 帯状疱疹ワクチン 卸業者
  • 帯状疱疹ワクチン 顧客

第14章 市場の促進要因, 機会, 課題とリスク要因の分析

  • 帯状疱疹ワクチン 業界動向
  • 帯状疱疹ワクチン 市場の促進要因
  • 帯状疱疹ワクチン 市場の課題
  • 帯状疱疹ワクチン 市場の抑制要因

第15章 世界の帯状疱疹ワクチンの主な市場調査結果

第16章 付録

図表
  • Table 1. Global Shingles Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Zostavax
  • Table 3. Major Manufacturers of Shingrix
  • Table 4. Global Shingles Vaccine Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
  • Table 5. Global Shingles Vaccine Production by Region: 2017 VS 2021 VS 2028 (K Doses)
  • Table 6. Global Shingles Vaccine Production by Region (2017-2022) & (K Doses)
  • Table 7. Global Shingles Vaccine Production Market Share by Region (2017-2022)
  • Table 8. Global Shingles Vaccine Production by Region (2023-2028) & (K Doses)
  • Table 9. Global Shingles Vaccine Production Market Share by Region (2023-2028)
  • Table 10. Global Shingles Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 11. Global Shingles Vaccine Sales by Region (2017-2022) & (K Doses)
  • Table 12. Global Shingles Vaccine Sales Market Share by Region (2017-2022)
  • Table 13. Global Shingles Vaccine Sales by Region (2023-2028) & (K Doses)
  • Table 14. Global Shingles Vaccine Sales Market Share by Region (2023-2028)
  • Table 15. Global Shingles Vaccine Revenue by Region (2017-2022) & (US$ Million)
  • Table 16. Global Shingles Vaccine Revenue Market Share by Region (2017-2022)
  • Table 17. Global Shingles Vaccine Revenue by Region (2023-2028) & (US$ Million)
  • Table 18. Global Shingles Vaccine Revenue Market Share by Region (2023-2028)
  • Table 19. Global Shingles Vaccine Production Capacity by Manufacturers (2017-2022) & (K Doses)
  • Table 20. Global Shingles Vaccine Capacity Market Share by Manufacturers (2017-2022)
  • Table 21. Global Shingles Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
  • Table 22. Global Shingles Vaccine Sales Market Share by Manufacturers (2017-2022)
  • Table 23. Global Shingles Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 24. Global Shingles Vaccine Revenue Share by Manufacturers (2017-2022)
  • Table 25. Shingles Vaccine Price by Manufacturers 2017-2022 (USD/Dose)
  • Table 26. Global Shingles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 27. Global Shingles Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shingles Vaccine as of 2021)
  • Table 28. Shingles Vaccine Manufacturing Base Distribution and Headquarters
  • Table 29. Manufacturers Shingles Vaccine Product Offered
  • Table 30. Date of Manufacturers Enter into Shingles Vaccine Market
  • Table 31. Mergers & Acquisitions, Expansion Plans
  • Table 32. Global Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
  • Table 33. Global Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
  • Table 34. Global Shingles Vaccine Sales Share by Type (2017-2022)
  • Table 35. Global Shingles Vaccine Sales Share by Type (2023-2028)
  • Table 36. Global Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 37. Global Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 38. Global Shingles Vaccine Revenue Share by Type (2017-2022)
  • Table 39. Global Shingles Vaccine Revenue Share by Type (2023-2028)
  • Table 40. Shingles Vaccine Price by Type (2017-2022) & (USD/Dose)
  • Table 41. Global Shingles Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
  • Table 42. Global Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
  • Table 43. Global Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
  • Table 44. Global Shingles Vaccine Sales Share by Application (2017-2022)
  • Table 45. Global Shingles Vaccine Sales Share by Application (2023-2028)
  • Table 46. Global Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 47. Global Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 48. Global Shingles Vaccine Revenue Share by Application (2017-2022)
  • Table 49. Global Shingles Vaccine Revenue Share by Application (2023-2028)
  • Table 50. Shingles Vaccine Price by Application (2017-2022) & (USD/Dose)
  • Table 51. Global Shingles Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
  • Table 52. North America Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
  • Table 53. North America Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
  • Table 54. North America Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 55. North America Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 56. North America Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
  • Table 57. North America Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
  • Table 58. North America Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 59. North America Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 60. North America Shingles Vaccine Sales by Country (2017-2022) & (K Doses)
  • Table 61. North America Shingles Vaccine Sales by Country (2023-2028) & (K Doses)
  • Table 62. North America Shingles Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 63. North America Shingles Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 64. Europe Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
  • Table 65. Europe Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
  • Table 66. Europe Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 67. Europe Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 68. Europe Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
  • Table 69. Europe Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
  • Table 70. Europe Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 71. Europe Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 72. Europe Shingles Vaccine Sales by Country (2017-2022) & (K Doses)
  • Table 73. Europe Shingles Vaccine Sales by Country (2023-2028) & (K Doses)
  • Table 74. Europe Shingles Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 75. Europe Shingles Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 76. Asia Pacific Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
  • Table 77. Asia Pacific Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
  • Table 78. Asia Pacific Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 79. Asia Pacific Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 80. Asia Pacific Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
  • Table 81. Asia Pacific Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
  • Table 82. Asia Pacific Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 83. Asia Pacific Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 84. Asia Pacific Shingles Vaccine Sales by Region (2017-2022) & (K Doses)
  • Table 85. Asia Pacific Shingles Vaccine Sales by Region (2023-2028) & (K Doses)
  • Table 86. Asia Pacific Shingles Vaccine Revenue by Region (2017-2022) & (US$ Million)
  • Table 87. Asia Pacific Shingles Vaccine Revenue by Region (2023-2028) & (US$ Million)
  • Table 88. Latin America Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
  • Table 89. Latin America Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
  • Table 90. Latin America Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 91. Latin America Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 92. Latin America Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
  • Table 93. Latin America Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
  • Table 94. Latin America Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 95. Latin America Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 96. Latin America Shingles Vaccine Sales by Country (2017-2022) & (K Doses)
  • Table 97. Latin America Shingles Vaccine Sales by Country (2023-2028) & (K Doses)
  • Table 98. Latin America Shingles Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 99. Latin America Shingles Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 100. Middle East and Africa Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
  • Table 101. Middle East and Africa Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
  • Table 102. Middle East and Africa Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 103. Middle East and Africa Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 104. Middle East and Africa Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
  • Table 105. Middle East and Africa Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
  • Table 106. Middle East and Africa Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 107. Middle East and Africa Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 108. Middle East and Africa Shingles Vaccine Sales by Country (2017-2022) & (K Doses)
  • Table 109. Middle East and Africa Shingles Vaccine Sales by Country (2023-2028) & (K Doses)
  • Table 110. Middle East and Africa Shingles Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 111. Middle East and Africa Shingles Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 112. Merck Corporation Information
  • Table 113. Merck Description and Major Businesses
  • Table 114. Merck Shingles Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
  • Table 115. Merck Shingles Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Merck Recent Development
  • Table 117. GlaxoSmithKline Corporation Information
  • Table 118. GlaxoSmithKline Description and Major Businesses
  • Table 119. GlaxoSmithKline Shingles Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
  • Table 120. GlaxoSmithKline Shingles Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. GlaxoSmithKline Recent Development
  • Table 122. Key Raw Materials Lists
  • Table 123. Raw Materials Key Suppliers Lists
  • Table 124. Shingles Vaccine Distributors List
  • Table 125. Shingles Vaccine Customers List
  • Table 126. Shingles Vaccine Market Trends
  • Table 127. Shingles Vaccine Market Drivers
  • Table 128. Shingles Vaccine Market Challenges
  • Table 129. Shingles Vaccine Market Restraints
  • Table 130. Research Programs/Design for This Report
  • Table 131. Key Data Information from Secondary Sources
  • Table 132. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Shingles Vaccine Product Picture
  • Figure 2. Global Shingles Vaccine Market Share by Type in 2021 & 2028
  • Figure 3. Zostavax Product Picture
  • Figure 4. Shingrix Product Picture
  • Figure 5. Global Shingles Vaccine Market Share by Application in 2021 & 2028
  • Figure 6. Under 50 Years Old
  • Figure 7. 50-60 Years Old
  • Figure 8. 60-70 Years Old
  • Figure 9. Above 70 Years Old
  • Figure 10. Shingles Vaccine Report Years Considered
  • Figure 11. Global Shingles Vaccine Capacity, Production and Utilization (2017-2028) & (K Doses)
  • Figure 12. Global Shingles Vaccine Production Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 13. Global Shingles Vaccine Production Market Share by Region (2017-2022)
  • Figure 14. Global Shingles Vaccine Production Market Share by Region (2023-2028)
  • Figure 15. Shingles Vaccine Production Growth Rate in North America (2017-2028) & (K Doses)
  • Figure 16. Shingles Vaccine Production Growth Rate in Europe (2017-2028) & (K Doses)
  • Figure 17. Shingles Vaccine Production Growth Rate in China (2017-2028) & (K Doses)
  • Figure 18. Shingles Vaccine Production Growth Rate in Japan (2017-2028) & (K Doses)
  • Figure 19. Global Shingles Vaccine Sales 2017-2028 (K Doses)
  • Figure 20. Global Shingles Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 21. Global Shingles Vaccine Revenue 2017-2028 (US$ Million)
  • Figure 22. Global Shingles Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 23. Global Shingles Vaccine Sales Market Share by Region (2017-2022)
  • Figure 24. Global Shingles Vaccine Sales Market Share by Region (2023-2028)
  • Figure 25. North America Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
  • Figure 26. North America Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. Europe Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
  • Figure 28. Europe Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 29. Asia-Pacific Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
  • Figure 30. Asia-Pacific Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 31. Latin America Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
  • Figure 32. Latin America Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 33. Middle East & Africa Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
  • Figure 34. Middle East & Africa Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 35. The Shingles Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 36. The Top 5 and 10 Largest Manufacturers of Shingles Vaccine in the World: Market Share by Shingles Vaccine Revenue in 2021
  • Figure 37. Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 38. Global Shingles Vaccine Sales Market Share by Type (2017-2028)
  • Figure 39. Global Shingles Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 40. Global Shingles Vaccine Sales Market Share by Application (2017-2028)
  • Figure 41. Global Shingles Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 42. North America Shingles Vaccine Sales Market Share by Type (2017-2028)
  • Figure 43. North America Shingles Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 44. North America Shingles Vaccine Sales Market Share by Application (2017-2028)
  • Figure 45. North America Shingles Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 46. North America Shingles Vaccine Sales Share by Country (2017-2028)
  • Figure 47. North America Shingles Vaccine Revenue Share by Country (2017-2028)
  • Figure 48. U.S. Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 49. Canada Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 50. Europe Shingles Vaccine Sales Market Share by Type (2017-2028)
  • Figure 51. Europe Shingles Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 52. Europe Shingles Vaccine Sales Market Share by Application (2017-2028)
  • Figure 53. Europe Shingles Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 54. Europe Shingles Vaccine Sales Share by Country (2017-2028)
  • Figure 55. Europe Shingles Vaccine Revenue Share by Country (2017-2028)
  • Figure 56. Germany Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 57. France Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 58. U.K. Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 59. Italy Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 60. Russia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 61. Asia Pacific Shingles Vaccine Sales Market Share by Type (2017-2028)
  • Figure 62. Asia Pacific Shingles Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 63. Asia Pacific Shingles Vaccine Sales Market Share by Application (2017-2028)
  • Figure 64. Asia Pacific Shingles Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 65. Asia Pacific Shingles Vaccine Sales Share by Region (2017-2028)
  • Figure 66. Asia Pacific Shingles Vaccine Revenue Share by Region (2017-2028)
  • Figure 67. China Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 68. Japan Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 69. South Korea Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 70. India Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 71. Australia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 72. Taiwan Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 73. Indonesia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 74. Thailand Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 75. Malaysia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 76. Philippines Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 77. Latin America Shingles Vaccine Sales Market Share by Type (2017-2028)
  • Figure 78. Latin America Shingles Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 79. Latin America Shingles Vaccine Sales Market Share by Application (2017-2028)
  • Figure 80. Latin America Shingles Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 81. Latin America Shingles Vaccine Sales Share by Country (2017-2028)
  • Figure 82. Latin America Shingles Vaccine Revenue Share by Country (2017-2028)
  • Figure 83. Mexico Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 84. Brazil Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 85. Argentina Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 86. Middle East and Africa Shingles Vaccine Sales Market Share by Type (2017-2028)
  • Figure 87. Middle East and Africa Shingles Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 88. Middle East and Africa Shingles Vaccine Sales Market Share by Application (2017-2028)
  • Figure 89. Middle East and Africa Shingles Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 90. Middle East and Africa Shingles Vaccine Sales Share by Country (2017-2028)
  • Figure 91. Middle East and Africa Shingles Vaccine Revenue Share by Country (2017-2028)
  • Figure 92. Turkey Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 93. Saudi Arabia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 94. U.A.E Shingles Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 95. Shingles Vaccine Value Chain
  • Figure 96. Shingles Vaccine Production Process
  • Figure 97. Channels of Distribution
  • Figure 98. Distributors Profiles
  • Figure 99. Bottom-up and Top-down Approaches for This Report
  • Figure 100. Data Triangulation
  • Figure 101. Key Executives Interviewed
目次

This research report focuses on the Shingles Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Shingles Vaccine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Shingles Vaccine Market Size by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Zostavax
    • 1.2.3 Shingrix
  • 1.3 Market by Application
    • 1.3.1 Global Shingles Vaccine Market Size by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Under 50 Years Old
    • 1.3.3 50-60 Years Old
    • 1.3.4 60-70 Years Old
    • 1.3.5 Above 70 Years Old
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Shingles Vaccine Production

  • 2.1 Global Shingles Vaccine Production Capacity (2017-2028)
  • 2.2 Global Shingles Vaccine Production by Region: 2017 VS 2021 VS 2028
  • 2.3 Global Shingles Vaccine Production by Region
    • 2.3.1 Global Shingles Vaccine Historic Production by Region (2017-2022)
    • 2.3.2 Global Shingles Vaccine Forecasted Production by Region (2023-2028)
  • 2.4 North America
  • 2.5 Europe
  • 2.6 China
  • 2.7 Japan

3 Global Shingles Vaccine Sales in Volume & Value Estimates and Forecasts

  • 3.1 Global Shingles Vaccine Sales Estimates and Forecasts 2017-2028
  • 3.2 Global Shingles Vaccine Revenue Estimates and Forecasts 2017-2028
  • 3.3 Global Shingles Vaccine Revenue by Region: 2017 VS 2021 VS 2028
  • 3.4 Global Shingles Vaccine Sales by Region
    • 3.4.1 Global Shingles Vaccine Sales by Region (2017-2022)
    • 3.4.2 Global Sales Shingles Vaccine by Region (2023-2028)
  • 3.5 Global Shingles Vaccine Revenue by Region
    • 3.5.1 Global Shingles Vaccine Revenue by Region (2017-2022)
    • 3.5.2 Global Shingles Vaccine Revenue by Region (2023-2028)
  • 3.6 North America
  • 3.7 Europe
  • 3.8 Asia-Pacific
  • 3.9 Latin America
  • 3.10 Middle East & Africa

4 Competition by Manufactures

  • 4.1 Global Shingles Vaccine Production Capacity by Manufacturers
  • 4.2 Global Shingles Vaccine Sales by Manufacturers
    • 4.2.1 Global Shingles Vaccine Sales by Manufacturers (2017-2022)
    • 4.2.2 Global Shingles Vaccine Sales Market Share by Manufacturers (2017-2022)
    • 4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Shingles Vaccine in 2021
  • 4.3 Global Shingles Vaccine Revenue by Manufacturers
    • 4.3.1 Global Shingles Vaccine Revenue by Manufacturers (2017-2022)
    • 4.3.2 Global Shingles Vaccine Revenue Market Share by Manufacturers (2017-2022)
    • 4.3.3 Global Top 10 and Top 5 Companies by Shingles Vaccine Revenue in 2021
  • 4.4 Global Shingles Vaccine Sales Price by Manufacturers
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.5.3 Global Shingles Vaccine Manufacturers Geographical Distribution
  • 4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Shingles Vaccine Sales by Type
    • 5.1.1 Global Shingles Vaccine Historical Sales by Type (2017-2022)
    • 5.1.2 Global Shingles Vaccine Forecasted Sales by Type (2023-2028)
    • 5.1.3 Global Shingles Vaccine Sales Market Share by Type (2017-2028)
  • 5.2 Global Shingles Vaccine Revenue by Type
    • 5.2.1 Global Shingles Vaccine Historical Revenue by Type (2017-2022)
    • 5.2.2 Global Shingles Vaccine Forecasted Revenue by Type (2023-2028)
    • 5.2.3 Global Shingles Vaccine Revenue Market Share by Type (2017-2028)
  • 5.3 Global Shingles Vaccine Price by Type
    • 5.3.1 Global Shingles Vaccine Price by Type (2017-2022)
    • 5.3.2 Global Shingles Vaccine Price Forecast by Type (2023-2028)

6 Market Size by Application

  • 6.1 Global Shingles Vaccine Sales by Application
    • 6.1.1 Global Shingles Vaccine Historical Sales by Application (2017-2022)
    • 6.1.2 Global Shingles Vaccine Forecasted Sales by Application (2023-2028)
    • 6.1.3 Global Shingles Vaccine Sales Market Share by Application (2017-2028)
  • 6.2 Global Shingles Vaccine Revenue by Application
    • 6.2.1 Global Shingles Vaccine Historical Revenue by Application (2017-2022)
    • 6.2.2 Global Shingles Vaccine Forecasted Revenue by Application (2023-2028)
    • 6.2.3 Global Shingles Vaccine Revenue Market Share by Application (2017-2028)
  • 6.3 Global Shingles Vaccine Price by Application
    • 6.3.1 Global Shingles Vaccine Price by Application (2017-2022)
    • 6.3.2 Global Shingles Vaccine Price Forecast by Application (2023-2028)

7 North America

  • 7.1 North America Shingles Vaccine Market Size by Type
    • 7.1.1 North America Shingles Vaccine Sales by Type (2017-2028)
    • 7.1.2 North America Shingles Vaccine Revenue by Type (2017-2028)
  • 7.2 North America Shingles Vaccine Market Size by Application
    • 7.2.1 North America Shingles Vaccine Sales by Application (2017-2028)
    • 7.2.2 North America Shingles Vaccine Revenue by Application (2017-2028)
  • 7.3 North America Shingles Vaccine Sales by Country
    • 7.3.1 North America Shingles Vaccine Sales by Country (2017-2028)
    • 7.3.2 North America Shingles Vaccine Revenue by Country (2017-2028)
    • 7.3.3 U.S.
    • 7.3.4 Canada

8 Europe

  • 8.1 Europe Shingles Vaccine Market Size by Type
    • 8.1.1 Europe Shingles Vaccine Sales by Type (2017-2028)
    • 8.1.2 Europe Shingles Vaccine Revenue by Type (2017-2028)
  • 8.2 Europe Shingles Vaccine Market Size by Application
    • 8.2.1 Europe Shingles Vaccine Sales by Application (2017-2028)
    • 8.2.2 Europe Shingles Vaccine Revenue by Application (2017-2028)
  • 8.3 Europe Shingles Vaccine Sales by Country
    • 8.3.1 Europe Shingles Vaccine Sales by Country (2017-2028)
    • 8.3.2 Europe Shingles Vaccine Revenue by Country (2017-2028)
    • 8.3.3 Germany
    • 8.3.4 France
    • 8.3.5 U.K.
    • 8.3.6 Italy
    • 8.3.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Shingles Vaccine Market Size by Type
    • 9.1.1 Asia Pacific Shingles Vaccine Sales by Type (2017-2028)
    • 9.1.2 Asia Pacific Shingles Vaccine Revenue by Type (2017-2028)
  • 9.2 Asia Pacific Shingles Vaccine Market Size by Application
    • 9.2.1 Asia Pacific Shingles Vaccine Sales by Application (2017-2028)
    • 9.2.2 Asia Pacific Shingles Vaccine Revenue by Application (2017-2028)
  • 9.3 Asia Pacific Shingles Vaccine Sales by Region
    • 9.3.1 Asia Pacific Shingles Vaccine Sales by Region (2017-2028)
    • 9.3.2 Asia Pacific Shingles Vaccine Revenue by Region (2017-2028)
    • 9.3.3 China
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 India
    • 9.3.7 Australia
    • 9.3.8 Taiwan
    • 9.3.9 Indonesia
    • 9.3.10 Thailand
    • 9.3.11 Malaysia
    • 9.3.12 Philippines

10 Latin America

  • 10.1 Latin America Shingles Vaccine Market Size by Type
    • 10.1.1 Latin America Shingles Vaccine Sales by Type (2017-2028)
    • 10.1.2 Latin America Shingles Vaccine Revenue by Type (2017-2028)
  • 10.2 Latin America Shingles Vaccine Market Size by Application
    • 10.2.1 Latin America Shingles Vaccine Sales by Application (2017-2028)
    • 10.2.2 Latin America Shingles Vaccine Revenue by Application (2017-2028)
  • 10.3 Latin America Shingles Vaccine Sales by Country
    • 10.3.1 Latin America Shingles Vaccine Sales by Country (2017-2028)
    • 10.3.2 Latin America Shingles Vaccine Revenue by Country (2017-2028)
    • 10.3.3 Mexico
    • 10.3.4 Brazil
    • 10.3.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Shingles Vaccine Market Size by Type
    • 11.1.1 Middle East and Africa Shingles Vaccine Sales by Type (2017-2028)
    • 11.1.2 Middle East and Africa Shingles Vaccine Revenue by Type (2017-2028)
  • 11.2 Middle East and Africa Shingles Vaccine Market Size by Application
    • 11.2.1 Middle East and Africa Shingles Vaccine Sales by Application (2017-2028)
    • 11.2.2 Middle East and Africa Shingles Vaccine Revenue by Application (2017-2028)
  • 11.3 Middle East and Africa Shingles Vaccine Sales by Country
    • 11.3.1 Middle East and Africa Shingles Vaccine Sales by Country (2017-2028)
    • 11.3.2 Middle East and Africa Shingles Vaccine Revenue by Country (2017-2028)
    • 11.3.3 Turkey
    • 11.3.4 Saudi Arabia
    • 11.3.5 U.A.E

12 Corporate Profiles

  • 12.1 Merck
    • 12.1.1 Merck Corporation Information
    • 12.1.2 Merck Overview
    • 12.1.3 Merck Shingles Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.1.4 Merck Shingles Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.1.5 Merck Recent Developments
  • 12.2 GlaxoSmithKline
    • 12.2.1 GlaxoSmithKline Corporation Information
    • 12.2.2 GlaxoSmithKline Overview
    • 12.2.3 GlaxoSmithKline Shingles Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.2.4 GlaxoSmithKline Shingles Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.2.5 GlaxoSmithKline Recent Developments

13 Industry Chain and Sales Channels Analysis

  • 13.1 Shingles Vaccine Industry Chain Analysis
  • 13.2 Shingles Vaccine Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Shingles Vaccine Production Mode & Process
  • 13.4 Shingles Vaccine Sales and Marketing
    • 13.4.1 Shingles Vaccine Sales Channels
    • 13.4.2 Shingles Vaccine Distributors
  • 13.5 Shingles Vaccine Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 14.1 Shingles Vaccine Industry Trends
  • 14.2 Shingles Vaccine Market Drivers
  • 14.3 Shingles Vaccine Market Challenges
  • 14.4 Shingles Vaccine Market Restraints

15 Key Finding in The Global Shingles Vaccine Study

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details
  • 16.3 Disclaimer